Nifty
:
23587.50
Sensex
:
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)
Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Indegene Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 544172 | NSE: INDGN

NSE BSE
587.70
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  608.00
  •  615.05
  •  585.10
  •  606.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  443045
  •  2662.23
  •  736.30
  •  470.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 14,065.42
  • 41.77
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 13,515.72
  • N/A
  • 5.96

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 0.00%
  • 4.05%
  • 24.32%
  • FII
  • DII
  • Others
  • 4.82%
  • 1.75%
  • 65.06%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 27.20
  • -
  • 15.87

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 32.78
  • -
  • 11.99

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 33.79
  • -
  • 26.90

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
15.19
16.82
20.95
24.63
P/E Ratio
44.44
40.15
32.22
27.41
Revenue
2590
2853
3245
3727
EBITDA
505
577
668
775
Net Income
337
404
503
591
ROA
14.2
14.5
16.5
17.9
P/Bk Ratio
10.49
6.24
5.22
4.38
ROE
27.01
19.78
17.42
17.17
FCFF
319.4
402
482.95
565.44
FCFF Yield
2.07
2.6
3.13
3.66

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
686.80
635.70
8.04%
676.50
607.50
11.36%
673.00
632.20
6.45%
0.00
0.00
0
Expenses
560.70
514.60
8.96%
547.60
510.70
7.23%
534.30
534.80
-0.09%
0.00
0.00
0
EBITDA
126.10
121.10
4.13%
128.90
96.80
33.16%
138.70
97.40
42.40%
0.00
0.00
0
EBIDTM
18.36%
19.05%
19.05%
15.93%
20.61%
15.41%
0.00%
0.00%
Other Income
21.40
11.60
84.48%
22.50
28.50
-21.05%
23.20
13.10
77.10%
0.00
0.00
0
Interest
4.00
12.30
-67.48%
11.70
12.60
-7.14%
12.30
11.60
6.03%
0.00
0.00
0
Depreciation
19.40
19.80
-2.02%
20.10
20.20
-0.50%
18.50
19.70
-6.09%
0.00
0.00
0
PBT
124.10
100.60
23.36%
119.60
92.50
29.30%
133.50
79.20
68.56%
0.00
0.00
0
Tax
32.40
25.60
26.56%
31.90
24.10
32.37%
38.70
30.40
27.30%
0.00
0.00
0
PAT
91.70
75.00
22.27%
87.70
68.40
28.22%
94.80
48.80
94.26%
0.00
0.00
0
PATM
13.35%
11.80%
12.96%
11.26%
14.09%
7.72%
0.00%
0.00%
EPS
3.84
3.39
13.27%
3.66
3.09
18.45%
4.27
2.20
94.09%
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 17
Mar 16
Mar 15
Net Sales
-
2,589.60
2,306.10
1,664.61
966.27
472.06
343.75
233.52
Net Sales Growth
-
12.29%
38.54%
72.27%
104.69%
37.33%
47.20%
 
Cost Of Goods Sold
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit
-
2,589.60
2,306.10
1,664.61
966.27
472.06
343.75
233.52
GP Margin
-
100%
100%
100%
100%
100%
100%
100%
Total Expenditure
-
2,084.20
1,910.20
1,377.69
735.74
401.24
291.26
203.85
Power & Fuel Cost
-
0.00
0.00
0.00
0.00
1.51
1.00
1.09
% Of Sales
-
0%
0%
0%
0%
0.32%
0.29%
0.47%
Employee Cost
-
1,651.60
1,464.80
1,014.34
535.60
265.21
183.32
103.55
% Of Sales
-
63.78%
63.52%
60.94%
55.43%
56.18%
53.33%
44.34%
Manufacturing Exp.
-
168.10
200.60
214.41
119.40
45.53
43.22
54.63
% Of Sales
-
6.49%
8.70%
12.88%
12.36%
9.64%
12.57%
23.39%
General & Admin Exp.
-
242.80
223.50
137.04
74.79
85.37
58.76
43.07
% Of Sales
-
9.38%
9.69%
8.23%
7.74%
18.08%
17.09%
18.44%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
1.09
% Of Sales
-
0%
0%
0%
0%
0%
0%
0.47%
Miscellaneous Exp.
-
21.70
21.30
11.89
5.96
3.62
4.97
0.42
% Of Sales
-
0.84%
0.92%
0.71%
0.62%
0.77%
1.45%
0.18%
EBITDA
-
505.40
395.90
286.92
230.53
70.82
52.49
29.67
EBITDA Margin
-
19.52%
17.17%
17.24%
23.86%
15.00%
15.27%
12.71%
Other Income
-
76.30
58.20
25.89
30.65
0.24
3.50
3.97
Interest
-
49.40
31.30
5.96
6.96
9.66
2.46
2.37
Depreciation
-
76.10
59.80
33.45
25.55
19.12
15.19
7.46
PBT
-
456.20
363.00
273.39
228.67
42.28
38.34
23.81
Tax
-
121.90
96.90
63.68
45.78
3.20
2.91
5.48
Tax Rate
-
26.58%
26.69%
28.12%
19.76%
7.57%
7.59%
23.02%
PAT
-
336.70
266.10
164.76
185.67
39.08
35.43
18.33
PAT before Minority Interest
-
336.70
266.10
162.82
185.68
39.08
35.43
18.33
Minority Interest
-
0.00
0.00
1.94
-0.01
0.00
0.00
0.00
PAT Margin
-
13.00%
11.54%
9.90%
19.22%
8.28%
10.31%
7.85%
PAT Growth
-
26.53%
61.51%
-11.26%
375.10%
10.30%
93.29%
 
EPS
-
14.07
11.12
6.89
7.76
1.63
1.48
0.77

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
1,429.10
1,063.80
763.90
324.51
Share Capital
44.40
44.30
0.35
0.31
Total Reserves
1,353.30
1,001.70
757.79
319.79
Non-Current Liabilities
434.80
583.90
79.97
26.79
Secured Loans
333.40
394.30
10.94
17.69
Unsecured Loans
0.00
0.00
0.00
0.00
Long Term Provisions
43.20
35.00
26.47
12.30
Current Liabilities
610.90
489.10
440.44
199.43
Trade Payables
118.10
73.30
74.22
50.19
Other Current Liabilities
402.50
354.30
305.48
128.39
Short Term Borrowings
9.70
0.00
0.00
0.00
Short Term Provisions
80.60
61.50
60.74
20.84
Total Liabilities
2,474.80
2,136.80
1,284.31
559.30
Net Block
645.80
664.10
137.72
85.92
Gross Block
995.10
863.40
271.29
191.10
Accumulated Depreciation
258.20
199.30
133.56
105.19
Non Current Assets
684.00
688.10
154.29
100.01
Capital Work in Progress
0.00
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
35.00
20.30
16.48
14.03
Other Non Current Assets
3.20
3.70
0.08
0.06
Current Assets
1,790.80
1,448.70
1,130.03
459.29
Current Investments
796.50
614.00
119.86
0.00
Inventories
0.00
0.00
0.00
0.00
Sundry Debtors
648.00
642.00
443.91
285.40
Cash & Bank
191.00
85.80
517.30
139.90
Other Current Assets
155.30
70.70
42.49
33.34
Short Term Loans & Adv.
33.90
36.20
6.46
0.65
Net Current Assets
1,179.90
959.60
689.59
259.87
Total Assets
2,474.80
2,136.80
1,284.32
559.30

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
507.70
130.20
297.04
172.03
PBT
458.60
363.00
226.50
195.85
Adjustment
78.20
91.40
87.07
17.29
Changes in Working Capital
95.80
-216.00
53.82
8.51
Cash after chg. in Working capital
632.60
238.40
367.39
221.64
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-124.90
-108.20
-70.35
-49.61
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-327.20
-893.30
-160.21
-24.25
Net Fixed Assets
12.20
-38.00
-50.00
Net Investments
-223.50
-197.00
-119.90
Others
-115.90
-658.30
9.69
Cash from Financing Activity
-66.20
333.10
233.48
-131.51
Net Cash Inflow / Outflow
114.30
-430.00
370.31
16.28
Opening Cash & Equivalents
73.60
506.30
133.36
173.86
Closing Cash & Equivalent
188.60
73.60
506.28
133.36

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
62.96
47.22
34.28
16.23
ROA
14.60%
15.56%
17.66%
33.13%
ROE
27.56%
29.50%
30.20%
176.32%
ROCE
30.88%
35.20%
41.09%
68.54%
Fixed Asset Turnover
2.79
4.06
7.20
4.71
Receivable days
90.91
85.94
79.96
87.03
Inventory Days
0.00
0.00
0.00
0.00
Payable days
0.00
0.00
0.00
0.00
Cash Conversion Cycle
90.91
85.94
79.96
87.03
Total Debt/Equity
0.29
0.38
0.02
0.08
Interest Cover
10.28
12.60
38.98
34.27

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013

News Update:


  • Indegene unveils new center in Hyderabad
    18th Nov 2024, 14:29 PM

    This vast global footprint underscores Indegene’s ability to scale and meet the evolving needs of the world’s leading pharma organizations across markets

    Read More
  • Indegene - Quarterly Results
    28th Oct 2024, 19:04 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.